Nasdaq or NYSE related Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of August 2026

Nasdaq or NYSE listed Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of August 2026. Nasdaq and NYSE related Biotechnology: Pharmaceutical Preparations industry Largest Companies List by Market Cap as of August 2026

  1. Inventiva S.A.

    World Rank (Aug-2026)
    8,864
    Market Cap (Aug-2026)
    1.087 Billion USD
    World Rank (Jan-05-2024)
    18,116
    Market Cap (Jan-05-2024)
    0.192 Billion USD
    World Rank (Jul-30-2023)
    18,640
    Market Cap (Jul-30-2023)
    0.179 Billion USD
    World Rank (Dec-25-2022)
    18,377
    Market Cap (Dec-25-2022)
    0.187 Billion USD
    World Rank (Jan-07-2022)
    13,225
    Market Cap (Jan-07-2022)
    0.52 Billion USD
    Headquarters Country
    France
    Company Website
    INVENTIVA S.A.

  2. POINT Biopharma Global Inc.

    World Rank (Aug-2026)
    8,923
    World Rank (Jan-05-2024)
    8,923
    World Rank (Jul-30-2023)
    8,923
    Market Cap (Jul-30-2023)
    0.962 Billion USD
    World Rank (Dec-25-2022)
    10,135
    Market Cap (Dec-25-2022)
    0.727 Billion USD
    World Rank (Jan-07-2022)
    13,170
    Market Cap (Jan-07-2022)
    0.52 Billion USD
    Annual Revenue in USD
    227 Million USD
    Annual Operating Income in USD
    126 Million USD
    Annual Net Income in USD
    98 Million USD
    Annual Results for Period Ending
    For year ending December-2022
    Headquarters Country
    USA
    Company Profile
    POINT Biopharma Global Inc. is a Clinical Stage Global Pharmaceutical company focused on the development and commercialization of radioligand therapies for the treatment of cancer. The headquarters is in USA.
    Company Website
    POINT BIOPHARMA GLOBAL INC.

  3. Wave Life Sciences

    World Rank (Aug-2026)
    8,951
    Market Cap (Aug-2026)
    1.066 Billion USD
    World Rank (Jan-05-2024)
    11,188
    Market Cap (Jan-05-2024)
    0.631 Billion USD
    World Rank (Jul-30-2023)
    14,083
    Market Cap (Jul-30-2023)
    0.403 Billion USD
    World Rank (Dec-25-2022)
    11,621
    Market Cap (Dec-25-2022)
    0.566 Billion USD
    World Rank (Jan-07-2022)
    19,803
    Market Cap (Jan-07-2022)
    0.17 Billion USD
    Annual Revenue in USD
    40 Million USD
    Annual Net Income in USD
    -122 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Singapore
    Yahoo @ Nasdaq
    Company Website
    WAVE LIFE SCIENCES LTD.

  4. Avalo Therapeutics Inc.

    World Rank (Aug-2026)
    9,013
    Market Cap (Aug-2026)
    1.051 Billion USD
    World Rank (Jan-05-2024)
    31,979
    Market Cap (Jan-05-2024)
    0.007 Billion USD
    World Rank (Jul-30-2023)
    33,602
    Market Cap (Jul-30-2023)
    0.003 Billion USD
    World Rank (Dec-25-2022)
    25,537
    Market Cap (Dec-25-2022)
    0.047 Billion USD
    World Rank (Jan-07-2022)
    21,658
    Market Cap (Jan-07-2022)
    0.12 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -73 Million USD
    Annual Net Income in USD
    -78 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Company Profile
    Avalo Therapeutics, Inc. is a biopharmaceutical company that discover, develop and commercialize highly targeted therapeutics in areas of significant unmet clinical need. The headquarters is in USA.
    Facts About Company
    Avalo Therapeutics, Inc. company annual revenue is 18 million USD and annual net loss -41 million USD as on Dec-2022.
    Company Website
    AVALO THERAPEUTICS, INC.

  5. Lexicon Pharmaceuticals

    World Rank (Aug-2026)
    9,111
    Market Cap (Aug-2026)
    1.032 Billion USD
    World Rank (Jan-05-2024)
    14,138
    Market Cap (Jan-05-2024)
    0.390 Billion USD
    World Rank (Jul-30-2023)
    12,951
    Market Cap (Jul-30-2023)
    0.485 Billion USD
    World Rank (Dec-25-2022)
    14,430
    Market Cap (Dec-25-2022)
    0.368 Billion USD
    World Rank (Jan-07-2022)
    13,051
    Market Cap (Jan-07-2022)
    0.53 Billion USD
    Annual Revenue in USD
    50 Million USD
    Annual Operating Income in USD
    -49 Million USD
    Annual Net Income in USD
    -50 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ MunichGermany
    Company Profile
    Lexicon Pharmaceuticals is a Biopharmaceutical company that is applying a unique approach to gene science based on Nobel Prize winning technology to discover and develop precise medicines for people with serious, chronic conditions. The company annual revenue is 322.07 million USD and 202 employees as on 2019. The headquarters is in USA.
    Company Website
    LEXICON PHARMACEUTICALS
    Wikipedia
    Wikipedia

  6. Ardelyx

    World Rank (Aug-2026)
    9,194
    Market Cap (Aug-2026)
    1.012 Billion USD
    World Rank (Jan-05-2024)
    6,971
    Market Cap (Jan-05-2024)
    1.428 Billion USD
    World Rank (Jul-30-2023)
    9,735
    Market Cap (Jul-30-2023)
    0.828 Billion USD
    World Rank (Dec-25-2022)
    13,070
    Market Cap (Dec-25-2022)
    0.452 Billion USD
    World Rank (Jan-07-2022)
    22,233
    Market Cap (Jan-07-2022)
    0.11 Billion USD
    Annual Revenue in USD
    407 Million USD
    Annual Operating Income in USD
    -41 Million USD
    Annual Net Income in USD
    -62 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Frankfurt
    Company Profile

    Ardelyx is a Biotechnology company enabled to develop a pipeline of drug candidates designed to better manage complications related to kidney and cardiorenal diseases. The headquarters is in USA.

    Facts About Company

    Ardelyx Annual Total Revenue for year ending Dec-2022 was 52 million USD and and Net loss for year ending Dec-2022 was -67 million USD.

    Ardelyx Annual Total Revenue for year ending Dec-2021 was 10 million USD and and Net loss for year ending Dec-2021 was -158 million USD.

    As on 2022, Ardelyx has 133 employees.

    Company Website
    ARDELYX

  7. Annexon Inc.

    World Rank (Aug-2026)
    9,234
    Market Cap (Aug-2026)
    1.003 Billion USD
    World Rank (Jan-05-2024)
    14,389
    Market Cap (Jan-05-2024)
    0.375 Billion USD
    World Rank (Jul-30-2023)
    18,916
    Market Cap (Jul-30-2023)
    0.170 Billion USD
    World Rank (Dec-25-2022)
    16,605
    Market Cap (Dec-25-2022)
    0.260 Billion USD
    World Rank (Jan-07-2022)
    16,216
    Market Cap (Jan-07-2022)
    0.32 Billion USD
    Annual Operating Income in USD
    -216 Million USD
    Annual Net Income in USD
    -207 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Annexon Biosciences is a Clinical Stage Biopharmaceutical company discovering, developing and commercializing breakthrough therapeutics for autoimmune and neurodegenerative disease. It is having 38 employees as on September 2020. The headquarters is in USA.
    Company Website
    ANNEXON, INC.

  8. Janux Therapeutics Inc.

    World Rank (Aug-2026)
    9,315
    Market Cap (Aug-2026)
    0.986 Billion USD
    World Rank (Jan-05-2024)
    12,817
    Market Cap (Jan-05-2024)
    0.484 Billion USD
    World Rank (Jul-30-2023)
    11,423
    Market Cap (Jul-30-2023)
    0.617 Billion USD
    World Rank (Dec-25-2022)
    12,494
    Market Cap (Dec-25-2022)
    0.494 Billion USD
    World Rank (Jan-07-2022)
    10,875
    Market Cap (Jan-07-2022)
    0.77 Billion USD
    Annual Revenue in USD
    10 Million USD
    Annual Operating Income in USD
    -158 Million USD
    Annual Net Income in USD
    -114 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Company Website
    JANUX THERAPEUTICS, INC.

  9. Geron Corporation

    World Rank (Aug-2026)
    9,506
    Market Cap (Aug-2026)
    0.944 Billion USD
    World Rank (Jan-05-2024)
    7,962
    Market Cap (Jan-05-2024)
    1.135 Billion USD
    World Rank (Jul-30-2023)
    6,549
    Market Cap (Jul-30-2023)
    1.618 Billion USD
    World Rank (Dec-25-2022)
    9,612
    Market Cap (Dec-25-2022)
    0.797 Billion USD
    World Rank (Jan-07-2022)
    15,170
    Market Cap (Jan-07-2022)
    0.38 Billion USD
    Annual Operating Income in USD
    -69 Million USD
    Annual Net Income in USD
    -84 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Geron Corporation is a Late Stage Clinical Biopharmaceutical company focused on the development and potential commercialization of a first in class telomerase inhibitor, imetelstat, an innovative therapeutic for hematologic myeloid malignancies. The headquarters is in USA.

    Facts About Company

    Geron Corporation Annual Total Revenue for year ending Dec-2022 was 0.5 million USD and and Net loss for year ending Dec-2022 was -141 million USD.

    Geron Corporation Annual Total Revenue for year ending Dec-2021 was 1.3 million USD and and Net loss for year ending Dec-2021 was =116 million USD.

    As on 2022, Geron Corporation has 107 employees.

    Company Website
    GERON CORPORATION
    Wikipedia
    Wikipedia

  10. Olema Pharmaceuticals Inc.

    World Rank (Aug-2026)
    9,573
    Market Cap (Aug-2026)
    0.930 Billion USD
    World Rank (Jan-05-2024)
    10,291
    Market Cap (Jan-05-2024)
    0.733 Billion USD
    World Rank (Jul-30-2023)
    15,099
    Market Cap (Jul-30-2023)
    0.343 Billion USD
    World Rank (Dec-25-2022)
    21,255
    Market Cap (Dec-25-2022)
    0.107 Billion USD
    World Rank (Jan-07-2022)
    16,820
    Market Cap (Jan-07-2022)
    0.29 Billion USD
    Annual Operating Income in USD
    -179 Million USD
    Annual Net Income in USD
    -162 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Olema Pharmaceuticals is a Clinical Stage Biopharmaceutical company. It is committed to the discovery, development and commercialization of a transformational generation of targeted therapies for women’s cancers. The headquarters is in USA.
    Company Website
    OLEMA PHARMACEUTICALS, INC.

Share